Vistra Corp.
Vistra Corp. (VST) Stock News
The latest VST headlines and market coverage — 2 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Microvast Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MVST
Rosen Law Firm has filed a class action lawsuit on behalf of Microvast Holdings investors who purchased securities between April 1, 2025 and March 16, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding margin targets, inventory management issues, delays in commercial vehicle rollouts, and the completion timeline of the Huzhou Phase 3.2 expansion. Investors must move the court by September 21, 2026 to serve as lead plaintiff.
- GlobeNewswire Inc.·
Atlas Healthcare Fund by VST Capital Entered Eli Lilly at $350 in 2020 — The Stock Now Trades Above $1,200
Atlas Healthcare Fund, managed by VST Capital, showcased its track record of early conviction investments in healthcare, with notable positions in Eli Lilly (entered at $350, now trading above $1,200), Alnylam Pharmaceuticals, TransMedics Group, and Inari Medical. The fund has delivered cumulative net returns of +1,720.9% since inception in January 2020, averaging over 57% annually, by identifying clinically differentiated technologies before mainstream market recognition.